Use access key #2 to skip to page content.
$3.78 0.24 (6.78%)
10/3/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

1

Avatar forbes10 (99.89) Submitted: 6/21/07 2:12 PM : Outperform Start Price: $12.96 MNKD Score: -44.17

Al Mann= Money in da bank

Report this Post Replies: 0 | Reply

Featured Broker Partners